Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 5 records, 1 pages
Search For: micafungin sodium for injection
Global Micafungin Sodium for Injection Supply, Demand and Key Producers, 2024-2030
09 Feb 2024
Pharma & Healthcare
Micafungin Sodium for Injection
The global Micafungin Sodium for Injection market size is expected to reach $ 297.9 million by 2030, rising at a market growth of -2.3% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Micafungin Sodium for Injection Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
Micafungin Sodium for Injection
According to our (Global Info Research) latest study, the global Micafungin Sodium for Injection market size was valued at USD 350.6 million in 2023 and is forecast to a readjusted size of USD 297.9 million by 2030 with a CAGR of -2.3% during review period.
USD3480.00
Add To Cart
Global Micafungin Sodium for Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
18 Mar 2023
Pharma & Healthcare
Micafungin Sodium for Injection
Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
USD3480.00
Add To Cart
Global Micafungin Sodium for Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
04 Jan 2022
Pharma & Healthcare
micafungin sodium for injection
The Micafungin Sodium for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
USD3480.00
Add To Cart
Global Micafungin Sodium for Injection Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
23 Mar 2021
Pharma & Healthcare
micafungin sodium for injection
The Micafungin Sodium for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
Search For: micafungin sodium for injection
Total: 5 records, 1 pages
The global Micafungin Sodium for Injection market size is expected to reach $ 297.9 million by 2030, rising at a market growth of -2.3% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Micafungin Sodium for Injection market size was valued at USD 350.6 million in 2023 and is forecast to a readjusted size of USD 297.9 million by 2030 with a CAGR of -2.3% during review period.
USD3480.00
Add To Cart
Micafungin (trade name Mycamine) is an echinocandin antifungal drug used to treat and prevent invasive fungal infections including candidemia, abscesses and esophageal candidiasis. It inhibits the production of beta-1,3-glucan, an essential component of fungal cell walls. Micafungin is administered intravenously. It received final approval from the U.S. Food and Drug Administration on March 16, 2005, and gained approval in the European Union on April 25, 2008.
USD3480.00
Add To Cart
The Micafungin Sodium for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
USD3480.00
Add To Cart
The Micafungin Sodium for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>